This prediction market asks whether the U.S. Centers for Disease Control and Prevention (CDC) will identify a new COVID-19 variant of concern between December 1, 2025, and December 31, 2026. The CDC classifies SARS-CoV-2 variants into three categories: Variants Being Monitored (VBM), Variants of Interest (VOI), and Variants of Concern (VOC). A VOC designation indicates a variant with evidence of increased transmissibility, more severe disease, significant reduction in neutralization by antibodies from prior infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures. The resolution relies on official CDC announcements, specifically updates to their variant classification scheme available on the CDC website. This market is part of a broader set of prediction markets tracking pandemic evolution and public health responses. As of early 2025, the dominant circulating lineages in the U.S. are descendants of the JN.1 variant, which the CDC classified as a VOI in December 2023 and later reclassified. No variant has been designated a VOC since the Omicron sublineages in 2022. The market reflects uncertainty about whether a new, more threatening variant will emerge within the next two years, a question that affects vaccine development, public health policy, and economic planning. Interest in this market is driven by the ongoing evolution of SARS-CoV-2, the potential for new waves of infection, and the need to prepare for future variants that could evade existing immunity. The outcome has implications for pharmaceutical companies, healthcare systems, and individuals making decisions about vaccination and travel.

Historical Context

The CDC first established a variant classification system in February 2021, adapting it from the WHO's framework. The first VOC designated by the CDC was the Alpha variant (B.1.1.7) in January 2021, which was 50% more transmissible than earlier strains. This was followed by Beta (B.1.351) in January 2021, Gamma (P.1) in February 2021, and Delta (B.1.617.2) in May 2021. The Omicron variant (B.1.1.529) was designated a VOC on November 30, 2021, and triggered a massive global wave of infections due to its high transmissibility and immune evasion. The CDC's classification scheme has undergone revisions. In September 2023, the agency streamlined its categories to VBM, VOI, and VOC, removing the 'Variant of High Consequence' category. Since then, several variants have been classified as VOIs, including BA.2.86 in August 2023 and JN.1 in December 2023, but none have been elevated to VOC status. The last VOC designation was for Omicron sublineages in early 2022. The virus has continued to evolve, with new lineages emerging that are descendants of Omicron, such as XBB and its sublineages. The absence of a new VOC since 2022 does not guarantee it will not happen again. Historical patterns show that SARS-CoV-2 can produce a new variant that meets VOC criteria every 6-12 months during periods of high transmission, but the pace of evolution has slowed as population immunity has increased.

Frequently Asked Questions